Trevi Therapeutics, Inc. SEC filings TRVI

Trevi Therapeutics, Inc. has 537 filings in SEC EDGAR's recent list, going back to Dec 18, 2012. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.

Trevi Therapeutics, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Sep 17, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 15, 2026 —
S-8 Employee stock plan registration Aug 6, 2026 —
10-Q Quarterly report Aug 6, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 6, 2026 Aug 6, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
4 Insider transaction Jun 4, 2026 Jun 3, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
4 Insider transaction Jun 4, 2026 Jun 3, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) May 7, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
DEF 14A Proxy statement Apr 21, 2026 Apr 21, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Dec 31, 2025
424B5 Prospectus supplement Apr 17, 2026 —
8-K Current report
Material agreement, Results of operations, Other events
Apr 17, 2026 Apr 16, 2026
424B5 Prospectus supplement Apr 16, 2026 —
PRE 14A Preliminary proxy statement Apr 10, 2026 Apr 10, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
8-K Current report
Other events
Mar 9, 2026 Mar 9, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
4 Insider transaction Feb 20, 2026 Feb 19, 2026
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
5 Annual insider ownership Feb 13, 2026 Dec 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 13, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 5, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 12, 2026 Jan 8, 2026
3 Initial insider ownership Jan 12, 2026 Jan 8, 2026
8-K Current report
Officer or director change
Dec 5, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
S-3ASR Automatic shelf registration Nov 13, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 17, 2025 —
144 Notice of proposed sale Oct 7, 2025 —
144 Notice of proposed sale Oct 3, 2025 —
144 Notice of proposed sale Aug 27, 2025 —
8-K Current report
Officer or director change
Aug 20, 2025 Aug 14, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 11, 2025 —
S-8 Employee stock plan registration Aug 7, 2025 —
10-Q Quarterly report Aug 7, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 7, 2025 Aug 7, 2025
SCHEDULE 13G Ownership over 5% (passive) Jul 9, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 17, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
4 Insider transaction Jun 13, 2025 Jun 11, 2025
8-K Current report
Material agreement, Other events
Jun 4, 2025 Jun 3, 2025
424B5 Prospectus supplement Jun 4, 2025 —
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
4 Insider transaction Jun 3, 2025 May 31, 2025
424B5 Prospectus supplement Jun 2, 2025 —
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
8-K Current report
Other events
Jun 2, 2025 Jun 2, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 29, 2025 —
ARS Annual report to shareholders Apr 29, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 29, 2025 Apr 29, 2025
4 Insider transaction Mar 26, 2025 Mar 25, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
144 Notice of proposed sale Mar 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 20, 2025 —
S-8 Employee stock plan registration Mar 18, 2025 —
10-K Annual report Mar 18, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 18, 2025 Mar 18, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
4 Insider transaction Mar 12, 2025 Mar 10, 2025
8-K Current report
Other events
Mar 10, 2025 Mar 10, 2025
144 Notice of proposed sale Mar 10, 2025 —
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
4 Insider transaction Jan 10, 2025 Jan 7, 2025
8-K Current report
Results of operations, Other events
Jan 8, 2025 Jan 8, 2025
4 Insider transaction Dec 17, 2024 Dec 13, 2024
8-K Current report
Material agreement, Other events
Dec 16, 2024 Dec 15, 2024
424B5 Prospectus supplement Dec 16, 2024 —
8-K Current report
Other events
Dec 12, 2024 Dec 12, 2024
8-K Current report
Other events
Dec 3, 2024 Dec 3, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13D/A Amended ownership over 5% (active) Nov 8, 2024 —
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
8-K Current report
Other events
Oct 21, 2024 Oct 21, 2024
8-K Current report
Other events
Oct 4, 2024 Oct 3, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
8-K Current report
Officer or director change
Oct 1, 2024 Sep 27, 2024
4 Insider transaction Sep 9, 2024 Sep 6, 2024
4 Insider transaction Sep 5, 2024 Sep 3, 2024
144 Notice of proposed sale Sep 3, 2024 —
4 Insider transaction Aug 29, 2024 Aug 27, 2024
144 Notice of proposed sale Aug 27, 2024 —
4 Insider transaction Aug 21, 2024 Aug 19, 2024
4 Insider transaction Aug 16, 2024 Aug 14, 2024
144/A Filing Aug 15, 2024 —
144 Notice of proposed sale Aug 15, 2024 —
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 8, 2024 Aug 8, 2024
SC 13G/A Amended ownership over 5% (passive) Jul 11, 2024 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 10, 2024 —
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
4 Insider transaction Jun 14, 2024 Jun 13, 2024
8-K Current report
Shareholder vote results
Jun 13, 2024 Jun 13, 2024
4 Insider transaction May 31, 2024 May 29, 2024
144 Notice of proposed sale May 29, 2024 —
4 Insider transaction May 24, 2024 May 22, 2024
4 Insider transaction May 22, 2024 May 20, 2024
SC 13D/A Amended ownership over 5% (active) May 21, 2024 —
4 Insider transaction May 14, 2024 May 10, 2024
10-Q Quarterly report May 7, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 7, 2024 May 7, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 13, 2024
SC 13G/A Amended ownership over 5% (passive) Apr 25, 2024 —
S-8 Employee stock plan registration Mar 20, 2024 —
10-K Annual report Mar 20, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 20, 2024 Mar 20, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
4 Insider transaction Feb 16, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 12, 2024 —
10-Q Quarterly report Nov 9, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 9, 2023 Nov 9, 2023
4 Insider transaction Oct 12, 2023 Oct 11, 2023
4 Insider transaction Sep 13, 2023 Sep 11, 2023
144 Notice of proposed sale Sep 11, 2023 —
EFFECT Filing Aug 15, 2023 —
CORRESP Letter to the SEC Aug 14, 2023 —
4 Insider transaction Aug 14, 2023 Aug 11, 2023
S-3/A Filing Aug 11, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 10, 2023 Aug 10, 2023
4 Insider transaction Jul 12, 2023 Jul 11, 2023
UPLOAD Letter from the SEC Jul 5, 2023 —
4 Insider transaction Jun 30, 2023 Jun 28, 2023
4 Insider transaction Jun 30, 2023 Jun 28, 2023
4 Insider transaction Jun 30, 2023 Jun 28, 2023
4 Insider transaction Jun 30, 2023 Jun 28, 2023
4 Insider transaction Jun 30, 2023 Jun 28, 2023
4 Insider transaction Jun 30, 2023 Jun 28, 2023
S-3 Shelf registration Jun 29, 2023 —
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 29, 2023 Jun 28, 2023
4 Insider transaction Jun 21, 2023 Jun 20, 2023
4 Insider transaction Jun 14, 2023 Jun 12, 2023
144 Notice of proposed sale Jun 12, 2023 —
4 Insider transaction May 15, 2023 May 11, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TRVI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New Haven, CT
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1563880

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.